Emeritus Professor Lloyd Sansom to lead TGA review.
The government has announced an independent review of the Therapeutic Goods Administration’s (TGA) regulation of medicines and medical devices, headed by Emeritus Professor Lloyd Sansom.
In announcing the “landmark review”, Health Minister Peter Dutton and Assistant Health Minister Fiona Nash also confirmed a review of the regulatory framework for the complementary medicines sector would occur in the second quarter of next year.
University of South Australia Division of Health Sciences School of Pharmacy and Medical Sciences Emeritus Professor Lloyd Sansom had played a major role in the development of the National Medicines Policy and was a former chair of the Pharmaceutical Benefits Advisory Committee, the Minister and Assistant Minister said in a joint release today.
Sansom would be assisted by Will Delaat and Professor John Horvath in the “landmark review” of the way in which the TGA regulated medicines and medical devices, the Minister and Assistant Minister said.
The review would look at areas of unnecessary, duplicative or ineffective regulation that could be removed or streamlined, and ways to enhance regulatory framework so the country continued to be well positioned to respond effectively to trends in the development, marketing and regulation of therapeutic goods, the government said.
Dutton said a modern regulatory framework was needed to allow Australians access to treatments in a timely manner.
A discussion paper would be released in the near future, with recommendations for prescription and OTC medicines and medical devices given by 31 Mar 2015, the government said.
For more, see Monday’s Pharmacy Daily.
